These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10907595)

  • 21. Safety Study of Salmeterol in Asthma in Adults.
    Hasegawa T; Uno H; Wei LJ
    N Engl J Med; 2016 Sep; 375(11):1097. PubMed ID: 27626533
    [No Abstract]   [Full Text] [Related]  

  • 22. Safety Study of Salmeterol in Asthma in Adults.
    Wilsdon T; Kichenadasse G; Rowland A
    N Engl J Med; 2016 Sep; 375(11):1096-7. PubMed ID: 27626532
    [No Abstract]   [Full Text] [Related]  

  • 23. Safety Study of Salmeterol in Asthma in Adults.
    Stempel DA; Yeakey AM; Pascoe SJ
    N Engl J Med; 2016 Sep; 375(11):1098. PubMed ID: 27626531
    [No Abstract]   [Full Text] [Related]  

  • 24. Salmeterol xinafoate in asthma.
    Palmer JB; Oxford JM
    JAMA; 1994 Nov 23-30; 272(20):1575-6. PubMed ID: 7966861
    [No Abstract]   [Full Text] [Related]  

  • 25. Salmeterol for the treatment of asthma.
    Weinberger M
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):209-11. PubMed ID: 7552921
    [No Abstract]   [Full Text] [Related]  

  • 26. Bronchodilator treatment in asthma. Manufacturers underestimate mortality from asthma.
    Inman WH
    BMJ; 1993 Jun; 306(6892):1610; author reply 1611. PubMed ID: 8101116
    [No Abstract]   [Full Text] [Related]  

  • 27. Bronchodilator treatment in asthma. Increase in deaths during salmeterol treatment unexplained.
    Sears MR; Taylor DR
    BMJ; 1993 Jun; 306(6892):1610-1. PubMed ID: 8101115
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S; Swystun VA; Bhagat R; Cockcroft DW
    Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bronchodilator treatment in asthma. Regular treatment with beta agonists remains unevaluated.
    Crompton GK
    BMJ; 1993 Jun; 306(6892):1610; author reply 1611. PubMed ID: 8101117
    [No Abstract]   [Full Text] [Related]  

  • 30. A stepwise approach to pediatric asthma.
    Dunn NA; Neff LA; Maurer DM
    J Fam Pract; 2017 May; 66(5):280-286. PubMed ID: 28459888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A word of caution regarding a new long-acting bronchodilator.
    Bone RC
    JAMA; 1994 May; 271(18):1447-8. PubMed ID: 7909854
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical Decisions. Mild persistent asthma--polling results.
    Fredenburgh LE; Campion EW; Drazen JM
    N Engl J Med; 2007 Jul; 357(2):179-80. PubMed ID: 17582063
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhaled corticosteroid therapy in asthma: a balancing act.
    Li JT
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):229-30. PubMed ID: 10094213
    [No Abstract]   [Full Text] [Related]  

  • 34. Bronchodilating effect of formoterol but not of salmeterol in two asthmatic patients.
    Noppen M; Vincken W
    Respiration; 2000; 67(1):112-3. PubMed ID: 10705276
    [No Abstract]   [Full Text] [Related]  

  • 35. Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma.
    Wiegand L; Mende CN; Zaidel G; Zwillich CW; Petrocella VJ; Yancey SW; Rickard KA
    Chest; 1999 Jun; 115(6):1525-32. PubMed ID: 10378544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
    JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature.
    Bisgaard H
    Pediatr Pulmonol; 2000 Mar; 29(3):221-34. PubMed ID: 10686044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salmeterol xinafoate vs albuterol in asthma: was race a factor?
    Olopade CO
    JAMA; 1994 Nov 23-30; 272(20):1576. PubMed ID: 7966862
    [No Abstract]   [Full Text] [Related]  

  • 39. Combination therapy with inhaled long-acting beta2-agonists and inhaled corticosteroids: a paradigm shift in asthma management.
    Stoloff S; Poinsett-Holmes K; Dorinsky PM
    Pharmacotherapy; 2002 Feb; 22(2):212-26. PubMed ID: 11837559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bronchodilator treatment in asthma. Study too small to detect increase in deaths.
    Bunney R
    BMJ; 1993 Jun; 306(6892):1610; author reply 1611. PubMed ID: 8101118
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.